Will Compass report net debt/EBITDA of 4.0x or below by Q2 2026 (first two quarters combined)?

The earnings update fundamentally narrows this question. Total debt is confirmed at $3.15B with no prepayment permitted before April 2027 — the numerator is fixed. The denominator must reach $788M TTM EBITDA for the ratio to hit 4.0x. Compass standalone FY2025 was $293M. Even assuming Anywhere contributes $350-400M annualized EBITDA and $50M in H1 synergies, the combined TTM EBITDA would be approximately $600-700M — well short of $788M. The no-prepayment covenant eliminates the numerator path entirely. The only scenario where this resolves YES is if Anywhere's EBITDA contribution is at the extreme high end (~$500M+) AND synergies ramp faster than the guided ~$5M Q1 / ramping through year schedule. This is possible but requires multiple optimistic assumptions to converge simultaneously.

Second-order consideration: how will TTM EBITDA even be calculated as of Q2 2026? The combined entity only exists from January 2026. Pro forma trailing twelve months would need to reconstruct Anywhere's pre-acquisition EBITDA, which adds complexity and potential for measurement disagreements. Management could potentially present a favorable pro forma TTM figure — but the market question likely requires the officially reported metric. If management reports a partial-year annualized figure rather than true TTM, the denominator could look different. However, even the most favorable pro forma reconstruction — using Anywhere's best recent quarters plus Compass's strong H2 — likely tops out around $700-750M, yielding 4.2-4.5x. The convertible notes at 0.25% help cash flow but don't reduce the debt balance. I see a narrow but non-trivial path if Anywhere's franchise EBITDA has been underestimated.

The pre-earnings estimate range of 3.4-4.4x has been decisively narrowed by the Q4 data. The 3.4x low-end estimate was premised on lower debt assumptions ($2.6B) — now confirmed at $3.15B. The cash position and undrawn revolver don't reduce gross debt in leverage calculations unless we're using net debt, and even then net debt is approximately $3.0B+ after subtracting ~$150M cash. The $3.0B / $788M = 3.8x net debt threshold is also demanding. Q1 seasonal weakness — Compass standalone was $15.6M in Q1 2025 — means the TTM denominator is dragged down unless Anywhere's Q1 is proportionally strong. Anywhere's franchise model provides more seasonal stability, but their title/escrow business is equally seasonal. The weight of evidence points strongly toward >4.0x at Q2 2026.

Simple arithmetic: $3.15B debt / 4.0x = $787.5M required TTM EBITDA. Compass FY2025 standalone: $293M. Anywhere needs to contribute ~$495M. Anywhere's franchise fees at 30-35% margins on >$1B revenue = $300-350M. Add title, escrow, relocation: maybe $100-150M more. Total Anywhere: $400-500M. Combined: $693-793M. At the midpoint ($743M), leverage = 4.24x. Only at the high end does it approach 4.0x. Add guided synergies (~$50M in H1 2026): $743M + $50M = $793M → 3.97x. But this requires everything at the high end plus full synergy capture. Base case is 4.2-4.5x.

The bull case deserves more weight than pure arithmetic suggests. Synergies of $175M actioned in 6.5 weeks (ahead of $250M Year 1 target) could translate to meaningful EBITDA uplift beyond the guided ~$100M in 2026. If synergy capture accelerates and $75-100M flows through by Q2, combined EBITDA could reach $750-800M. Additionally, Q2 is the seasonally strongest quarter — the TTM calculation as of Q2 2026 would include Q2's peak contribution. If Compass's growth trajectory continues (+80% YoY in Q3 2025), the standalone contribution could exceed $293M on an annualized basis. Still below 50% probability, but there is a credible path if synergies outperform.

The no-prepayment covenant is the decisive data point from this earnings update. Before, there was a plausible path via debt reduction using FCF. Now, the only path is through the denominator. The EBITDA math at midpoint estimates yields 4.2-4.5x. The resolution criterion checks 'as of Q2 2026' — meaning the Q2 10-Q filing must show this ratio. Given PPA is still being finalized and the first combined period is Q1 2026, the reported leverage figure may not even be directly comparable to the question's definition. Management may report different leverage metrics than net debt/TTM EBITDA.

$3.15B debt is fixed until April 2027. Need $788M EBITDA. Best estimates put combined at $600-750M. Math doesn't work unless everything goes perfectly. Previous 0.40 estimate was too high given the confirmed debt and no-prepayment constraint.

The earnings call confirmed the bear case. $3.15B debt, no prepayment, and combined EBITDA unlikely to reach $788M in the first two quarters of combined operations. Synergies are ahead of plan but $175M actioned doesn't mean $175M in EBITDA — actioned means identified/initiated, not realized. Q1 seasonal weakness further constrains the denominator.

Pro forma leverage starting at ~5.5x (using $3.15B / ~$575M estimated combined TTM EBITDA). Need to go from 5.5x to 4.0x purely through EBITDA growth — a 37% increase in EBITDA with fixed debt. Highly unlikely in 6 months. Even optimistic scenarios only get to 4.2-4.5x.